Pediatrics & Therapeutics
Open Access

Hyperlipidemia Due to Rectal Phenobarbital Use: Case Report

Kadir Serafettin Tekgunduz^1*, Eda Kepenekli², and Yasar Demirelli¹

¹Ataturk University Medicine Faculty, Division of Neonatology, Turkey

²Marmara University Medicine Faculty, Division of Pediatric Infectious Diseases, Turkey

*Corresponding Author:

Kadir Serafettin Tekgunduz
Ataturk University Medicine Faculty
Division of Neonatology
Erzurum, Turkey
Tel: +905056603769
E-mail: [email protected]

Received Date: August 02, 2013; Accepted Date: August 25, 2013; Published Date: August 29, 2013

Citation: Tekgunduz KS, Kepenekli E, Demirelli Y (2013) Hyperlipidemia Due to Rectal Phenobarbital Use: Case Report. Pediat Therapeut 3:165. doi:10.4172/2161-0665.1000165

Copyright: © 2013 Tekgunduz KS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF | Peer-reviewed Full Article

Treatment with hepatic enzyme-inducing antiepileptic drugs leads to increases in the levels of total cholesterol (TC) and triglyceride (TG). We report a case of a 10-monthold infant with hyperlipidemia due to use of rectal phenobarbital-paracetamol combination during echovirus infection. To the best of our knowledge, this is the first case reported in the literature of hyperlipidemia due to rectal phenobarbital use.